Journal of psychiatry & neuroscience : JPN

The most recent articles from: J Psychiatry Neurosci January 2014

J Psychiatry Neurosci · Jan 2014

Randomized Controlled Trial Multicenter Study

Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.

Major depressive disorder (MDD) is a global health concern. This study examined the efficacy, safety and tolerability of an extended-release (ER) formulation of levomilnacipran, an antidepressant approved for the treatment of MDD in adults. ⋯ NCT01377194.

read more… or not…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,706,642 articles already indexed!